期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

提高PLGA微球载蛋白多肽类药物稳定性添加剂的研究进展 被引量：5

Research progress of additives for improving therapeutic peptides and proteins stability in PLGA microspheres
原文传递
导出
摘要 聚乳酸-羟基乙酸共聚物（PLGA）包裹药物制成微球制剂是近年来药物输送体系的研究热点,但是PLGA包囊药物尤其是蛋白多肽类变性失活问题是研究的难点.改进生产工艺特别是使用添加剂可提高微球中包载药物的稳定性.综述了PLGA微球制备及释放过程中不同添加剂的作用特别是稳定蛋白药物的作用. Microspheres made of poly-lactic-co-glycolic acid （PLGA） have been frequently proposed as drug delivery systems. A very significant challenge in the development of controlled PLGA releasing systems is the instability of drugs especially therapeutic peptides and proteins. Additional approaches, particularly the use of additives, are needed to optimize PLGA delivery of drugs. This article reviews the effects of additives, especially the effects of stabilizing protein during the preparation of PLGA mierosphere and the sustained drug releasing processes.
作者 陈红丽 王永学 郭伟云 张其清
机构地区 新乡医学院生命科学技术系 中国医学科学院北京协和医学院生物医学工程研究所
出处 《国际生物医学工程杂志》 CAS 2012年第3期185-188,共4页 International Journal of Biomedical Engineering
基金 河南省教育厅自然科学研究计划项目（2011B310006） 天津市生物医学材料重点实验室开放课题（1116-3） 河南省医学科技攻关项目（201003072）
关键词 聚乳酸-羟基乙酸共聚物微球 添加剂 稳定性 蛋白多肽类药物 Poly-lactic-co-glycolic acid microspheres Additive Stability Therapeutic peptides and proteins
分类号 R943 [医药卫生—药剂学]
  • 相关文献

参考文献33

  • 1Okada H, Doken Y, Ogawa Y, et al. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers[J]. Pharm Res, 1994, 11(8): 1143-1147.
  • 2Mateovic-Rojnik T, Frlan R, Bogataj M, et al. Effect of preparation temperature in solvent evaporation process on Eudragit RS microsphere properties[J]. Chem Pharm Bull (Tokyo), 2005, 53 (1): 143- 146.
  • 3van de Ven H, Vermeersch M, Matheeussen A, et al. PLGA nanoparticles loaded with the antileishmanial saponin beta-aescin: factor influence study and in vitro efficacy evaluation [J]. Int J Pharm, 2011, 420(1): 122-132.
  • 4Ford AN, Pack DW, Braatz RD. Multi-scale modeling of PLGA microparticle drug delivery systems[J]. Computer Aided Chemical Engineering, 2011, 29: 1475-1479.
  • 5Bohr A, Kristensen J, Stride E, et al. Preparation of microspheres containing low solubility drug compound by electrohydrodynamic spraying[J]. Int J Pharm, 2011,412(1-2): 59-67.
  • 6Hamishehkar H, Emami J, Najafabadi AR, et al. The effect of formulation variables on the characteristics of insulin-loaded poly(lacticco-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method[J]. Colloids Surf B Biointerfaces, 2009, 74(1): 340-349.
  • 7Rawat A, Burgess DJ. USP apparatus 4 method for in vitro release testing of protein loaded mierospheres[J]. Int J Pharm, 2011,409(1-2): 178-184.
  • 8Li Zhi-ping, Li Lin, Liu Yan, et al. Development of interferon alpha2b microspheres with constant release[J]. Int J Phann, 2011,410(1-2): 48-53.
  • 9Yuan Wei-en, Zhang Yu-long, Wu Fei, et al. Preparation of proteinloaded sustained-release microspheres via "solid-in-oil-in-hydrophilic oil-in-ethanol (S/O/hO/E)" emulsification[J]. Colloids Surf B Biointeffaces, 2010, 79(2): 326-333.
  • 10Han Ya-dong, Tian Hua-yu, He Pan, et al. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system[J]. Int J Pharm, 2009, 378 (1-2): 159-166.

二级参考文献11

  • 1Lei L,Schwendeman SP.Mapping neutral microclimate pH in PLGA microspheres[J].J Controlled Release,2005,101 (2):163-173.
  • 2Anna S,Thomas GB,Steven PS.The acidic microclimate in poly (lactide-co-glycolide) microspheres stabilizes camptothecins.[J] Pharm Res,1999,16 (2):241-248.
  • 3Mayer LD,Masin D,Nayar R,et al.Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours[J].Br J Cancer,1995,71(9):482-488.
  • 4Gidding C,Kellie S,Kamps W,et al.Vincristine revisited[J].Crit Rev Oncol Hemafol,1999,29(3):267-287.
  • 5Vendrig D,Beijnen JH,Van Der Howwen O,et al.Degradation kinetics of vincristine sulphate and vindesine sulphate in aqueous solutions[J].Int J Pharm,1989,50(2):189-196.
  • 6Zhu G,Mallery SR,Schwendeman SP.Stabilisation of proteins encapsulated in injectable poly (lactide-co-glycolide)[J].Nat Biotechnol,2000,18(1):52-57.
  • 7Gupte A,Ciftci K.Formulation and characterization of Paclitaxel,5-FU and Paclitaxel + 5-FU microspheres[J].Int J Pharm,2004,276(1):93-106.
  • 8Huo DJ,Deng SH,Li LB,et al.Studies on the poly (lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting[J].Int J Pharm,2005,289(1):63-67.
  • 9Qian F,Stowe N,Erin H,et al.Quantification of in vivo doxombicin transport from PLGA millirods in thermoablated rat livers[J].J Control Release,2003,91 (1-2):157-166.
  • 10Kumar Naraharisetti P,Yung Sheng Ong B,Wei Xie J,et al.In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma[J].Biomaterials,2007,28(5):886-894.

共引文献7

同被引文献30

  • 1李卫红,司鹏,雷文.药用合成高分子缓、控释材料研究进展[J].高分子通报,2015(1):56-59. 被引量：10
  • 2杨帆,汪朝阳,潘育方,洪慧,赵耀明,徐安龙.聚乳酸-乙醇酸的合成及在药物缓释微球中的应用[J].高分子材料科学与工程,2005,21(3):77-80. 被引量：28
  • 3王襄平,梅兴国.乳酸/羟基乙酸共聚物的分子量及其单体组成比例对利培酮微球性质的影响[J].中国药房,2007,18(1):38-41. 被引量：13
  • 4Chen Y C,Hsieh W Y.Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier [J].Journal of Biomaterials Applications,2013,27(7):909-922.
  • 5Nafee N,Taetz S,Schneider M,et al.Chitosan-coated PLGA nanoparticles for DNA/RNA delivery:effect of the formulation parameters on complexation and transfection of antisense oligonucleotides[J].Nanotechnology,Biology and Medicine,2007,3(3):173-183.
  • 6Anand P.Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake,and increased bioactivity in vitro and superior bioavailability in vivo [J].Biochemical Pharmacology,2010,79(3):330-338.
  • 7Wang Y,Li P,Kong L,et al.Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery[J].Aaps Pharmscitech,2013,14(2):585-592.
  • 8Astete C E,Sabliov C M.Synthesis and characterization of PLGA nanoparticles [J].Journal of Biomaterials Science Polymer Edition,2006,17(3):247-289.
  • 9Yallapu M M,Gupta B K,Jaggi M,et al.Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells [J].Journal of Colloid & Interface Science,2010,351(1):19-29.
  • 10Mirakabad F,Akbarzadeh A,Zarghami N,et al.PLGA-based nanoparticles as cancer drug delivery systems [J].Asian Pacific Journal of Cancer Prevention Apjcp,2014,15(2):517-535.

引证文献5

二级引证文献22

国际生物医学工程杂志
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部